Black Swan Research Initiative: As We Move Ahead, What Will We Learn?
The Black Swan Research Initiative team has been busy since our spring launch. Team members are laying the groundwork for clinical trials and perfecting the extra-sensitive testing regimes that will allow us to measure minimal residual disease, identify pathways to cures, and improve treatments along the way.
We already know where we want to end up--curing this destructive disease--but as we move ahead our key focus is discovering the best route or routes, as the case may be, to get us there. As the Hungarian physician and Nobel Prize winner Albert Szent-Gyorgyi put it: "Research is to see what everybody else has seen and to think what nobody else has thought."
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.